<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0001645'>Sudden cardiac death</z:hpo> (SCD) is the main cause of <z:hpo ids='HP_0011420'>death</z:hpo> in patients with reduced left ventricular ejection fraction (LVEF) </plain></SENT>
<SENT sid="1" pm="."><plain>Implantation of an automatic cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) significantly reduces mortality of these patients </plain></SENT>
<SENT sid="2" pm="."><plain>T-wave alternans (TWA) analysis is a relatively new method of SCD risk stratification </plain></SENT>
<SENT sid="3" pm="."><plain>However, it's prognostic role in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> has not yet been fully established </plain></SENT>
<SENT sid="4" pm="."><plain>AIM: To assess the predictive value of TWA in patients with previously implanted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: The study included 67 patients with properly functioning <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> (54 men and 13 women, aged 62.2 ± 8.4 years) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients underwent TWA analysis on the treadmill using the Cambridge Heart 2000 system </plain></SENT>
<SENT sid="7" pm="."><plain>Results were considered as positive, negative or indeterminate </plain></SENT>
<SENT sid="8" pm="."><plain>Each patient had at least 1 clinical control visit with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> interrogation during the 12 ± ± 6 months of follow-up </plain></SENT>
<SENT sid="9" pm="."><plain>The recurrence of sustained <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo>: <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (VT) or <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>) was analysed </plain></SENT>
<SENT sid="10" pm="."><plain>RESULTS: No significant relationship was found between previous infarction (p = 0.810), aetiology (p = 0.768), LVEF (p = 0.413) or age (p = 0.562) and the incidence of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> during follow-up </plain></SENT>
<SENT sid="11" pm="."><plain>The results of TWA were not significantly different between patients with or without VT or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>The TWA analysis identified patients with <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> recurrences with a sensitivity of 62%, specificity of 49%, negative predictive value of 81%, and positive predictive value of 28% </plain></SENT>
<SENT sid="13" pm="."><plain>The TWA performance was better in patients with non-ischaemic than ischaemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> (negative predictive value: 100%, positive predictive value: 75%) </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: The TWA alternans was moderately effective for identification of patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> and <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo> recurrences </plain></SENT>
<SENT sid="15" pm="."><plain>The test was most useful for identification of patients with non-ischaemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> who are of low arrhythmic risk </plain></SENT>
</text></document>